Hydromorphon Stada (Hydromorphone Hydrochloride)

• Hydromorphone is an opioid analgesic used in the management of pain.
• Acute postoperative pain: provides rapid relief after surgical procedures.
• Cancer‑related pain: helps control severe pain associated with malignant disease.
• Chronic non‑cancer pain: employed when other analgesics are inadequate for long‑term severe pain.

• Hydromorphone binds as an agonist to the μ‑opioid receptors in the central nervous system. Activation of these receptors inhibits the release of neurotransmitters involved in pain transmission, leading to decreased perception of pain and increased analgesic effect. The drug also produces sedation by modulating neuronal activity in brain regions that regulate arousal.

Hydromorphone may cause a range of adverse reactions, from mild to serious. Patients should be informed of common and less frequent side effects.

Common Side Effects

• Nausea: feeling of sickness or urge to vomit.
• Constipation: reduced bowel movements and hard stools.
• Drowsiness: increased sleepiness or fatigue.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Dry mouth: reduced salivation leading to a parched feeling.
• Vomiting: expulsion of stomach contents.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Addiction or dependence: potential for misuse and physical dependence.
• Adrenal insufficiency: impaired cortisol production.
• Seizures: rare occurrence of convulsive episodes.

When prescribing or dispensing Hydromorphone, several safety considerations are essential.

• Assess pain level: confirm that opioid therapy is appropriate for the intensity of pain.
• Screen for respiratory disorders: avoid use in patients with severe asthma or COPD.
• Evaluate hepatic and renal function: dose adjustments may be required in impairment.
• Avoid concomitant CNS depressants: limit use with benzodiazepines or alcohol.
• Monitor for signs of dependence: watch for cravings, tolerance, or withdrawal.
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Hydromorphone can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid)

• Other opioids: additive respiratory depression.
• Benzodiazepines: increased risk of profound sedation and respiratory compromise.
• MAO inhibitors: potential for severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

• Anticholinergics: may worsen constipation and urinary retention.
• SSRIs or SNRIs: possible serotonin syndrome when combined.
• Alcohol: enhances CNS depression and impairs judgment.